Merck & Co., Inc.
Merck & Co., Inc. 6MK.DE Peers
See (6MK.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 6MK.DE | €70.90 | +2.46% | 178B | 11.82 | €6.00 | +3.75% |
| LLY.DE | €696.70 | +2.91% | 660.3B | 64.99 | €10.72 | +0.66% |
| JNJ.DE | €137.04 | +0.65% | 329.7B | 17.46 | €7.85 | +3.01% |
| 4AB.DE | €166.40 | -0.36% | 293.9B | 81.17 | €2.05 | +3.18% |
| ZEG.DE | €129.20 | +0.86% | 200.3B | 29.77 | €4.34 | +2.12% |
| AMG.DE | €258.35 | +1.41% | 138.9B | 27.00 | €9.57 | +3.28% |
| PFE.DE | €21.32 | +1.52% | 121.2B | 17.62 | €1.21 | +6.63% |
| PFE.F | €21.28 | +1.31% | 121B | 17.88 | €1.19 | +6.64% |
| GIS.DE | €96.92 | -1.82% | 120.6B | 23.30 | €4.16 | +2.73% |
| SNW.DE | €87.56 | -0.09% | 106.7B | 17.55 | €4.99 | +4.48% |
Stock Comparison
6MK.DE vs LLY.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, LLY.DE has a market cap of 660.3B. Regarding current trading prices, 6MK.DE is priced at €70.90, while LLY.DE trades at €696.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas LLY.DE's P/E ratio is 64.99. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, 6MK.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs JNJ.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, JNJ.DE has a market cap of 329.7B. Regarding current trading prices, 6MK.DE is priced at €70.90, while JNJ.DE trades at €137.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas JNJ.DE's P/E ratio is 17.46. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to JNJ.DE's ROE of +0.30%. Regarding short-term risk, 6MK.DE is more volatile compared to JNJ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs 4AB.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, 4AB.DE has a market cap of 293.9B. Regarding current trading prices, 6MK.DE is priced at €70.90, while 4AB.DE trades at €166.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas 4AB.DE's P/E ratio is 81.17. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, 6MK.DE is more volatile compared to 4AB.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs ZEG.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, ZEG.DE has a market cap of 200.3B. Regarding current trading prices, 6MK.DE is priced at €70.90, while ZEG.DE trades at €129.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas ZEG.DE's P/E ratio is 29.77. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, 6MK.DE is more volatile compared to ZEG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs AMG.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, AMG.DE has a market cap of 138.9B. Regarding current trading prices, 6MK.DE is priced at €70.90, while AMG.DE trades at €258.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas AMG.DE's P/E ratio is 27.00. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, 6MK.DE is less volatile compared to AMG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs PFE.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, PFE.DE has a market cap of 121.2B. Regarding current trading prices, 6MK.DE is priced at €70.90, while PFE.DE trades at €21.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas PFE.DE's P/E ratio is 17.62. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs PFE.F Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, PFE.F has a market cap of 121B. Regarding current trading prices, 6MK.DE is priced at €70.90, while PFE.F trades at €21.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas PFE.F's P/E ratio is 17.88. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, 6MK.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs GIS.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, GIS.DE has a market cap of 120.6B. Regarding current trading prices, 6MK.DE is priced at €70.90, while GIS.DE trades at €96.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas GIS.DE's P/E ratio is 23.30. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, 6MK.DE is less volatile compared to GIS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs SNW.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, SNW.DE has a market cap of 106.7B. Regarding current trading prices, 6MK.DE is priced at €70.90, while SNW.DE trades at €87.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas SNW.DE's P/E ratio is 17.55. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, 6MK.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BRM.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, BRM.DE has a market cap of 89.8B. Regarding current trading prices, 6MK.DE is priced at €70.90, while BRM.DE trades at €44.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas BRM.DE's P/E ratio is 18.85. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, 6MK.DE is less volatile compared to BRM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BAYN.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, BAYN.DE has a market cap of 26.3B. Regarding current trading prices, 6MK.DE is priced at €70.90, while BAYN.DE trades at €26.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas BAYN.DE's P/E ratio is -8.06. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs BAYN.SG Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, BAYN.SG has a market cap of 26.2B. Regarding current trading prices, 6MK.DE is priced at €70.90, while BAYN.SG trades at €26.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, 6MK.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs IDP.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, IDP.DE has a market cap of 17.5B. Regarding current trading prices, 6MK.DE is priced at €70.90, while IDP.DE trades at €119.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas IDP.DE's P/E ratio is 13.52. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, 6MK.DE is less volatile compared to IDP.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.
6MK.DE vs GS7.DE Comparison
6MK.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 6MK.DE stands at 178B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, 6MK.DE is priced at €70.90, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
6MK.DE currently has a P/E ratio of 11.82, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, 6MK.DE's ROE is +0.38%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, 6MK.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for 6MK.DE.